Researchers track blistering skin disease to pave way for better treatments

NCT ID NCT02753777

Recruiting now Knowledge-focused Sponsor: University of Pennsylvania Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how severe autoimmune blistering diseases like pemphigus and bullous pemphigoid are and how they affect quality of life. Researchers will enroll 150 adults to test disease severity scales and quality-of-life questionnaires. The goal is to create better tools for future clinical trials, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BULLOUS PEMPHIGOID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bullous pemphigoid pemphigus pemphigus foliaceus pemphigus vulgaris

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BULLOUS PEMPHIGOID PEMPHIGUS FOLIACEUS PEMPHIGUS VULGARIS

Contacts and locations

Locations

Hospital of the University of Pennsylvania
RECRUITING

Philadelphia, Pennsylvania, 19104, United States
Hospital of the University of Pennsylvania, Department of Dermatology
RECRUITING

Philadelphia, Pennsylvania, 19104, United States
University of Pennsylvania, Department of Dermatology
RECRUITING

Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.